BIO Investor Forum LinkedIn Group

Join the BIO Investor Forum LinkedIn Group


Now Open!

BIO Asia International Partnering Conference Registration

BIO CEO & Investor Conference Registration


New Updates


BIO Proudly Supports:


Windhover's Pharm Asia Summit

Focusing on strategic partnerships in Asia and emerging markets



Lead Bank Sponsor

Wedbush PacGro Life Sciences


Conference Co-Host

Rodman & Renshaw


BIO Double Helix Sponsor

BioGeorgia


BIO Helix Sponsors

Merck & Co., Inc.

North Carolina Biotechnology Center


Conference Sponsors

Biogen Idec

BioWorld

Campbell Alliance

Chubb Group of Insurance Agencies

Ernst & Young

Panel Intelligence

Thomson Reuters

VWR International


Conference Supporters

BIOTECanada

Business Wire

MedTRACK

Oxford Finance Corporation


 

Speaker Resource Center

 

About Company Presentations

The 8th Annual BIO Investor Forum assembles a select group of public and venture-stage growth companies, as well as top public and private equity investors, to explore investment trends and opportunities in life sciences. In addition to expert-led workshops and panel discussions focusing on industry trends, the conference features presentations by over 100 biotech companies poised to join the growth “watch list” in 2010, as well as a number of nonprofit and venture philanthropy organizations.

Presentations are scheduled in 25 minute slots within therapeutic tracks. The typical audience features public and private equity investors, as well as research analysts, investment bankers and industry executives.  Presenters can refer to The Speaker Resource Center for information regarding presentation logistics and submission, webcasting, and press and media, among other topics. If your question is not addressed here, please contact us at 866-356-5155 (+1.202.962.6666 International) or biopartnering@bio.org.

 

Upcoming Deadlines

Profile Publication for Conference CD: October 9, 2009

 

Selection Process

The 8th Annual BIO Investor Forum features a mix of later-stage private and early-stage public companies from around the globe. Companies selected to present focus on biotechnology therapeutics, as opposed to those exclusively developing medical devices, platform technologies, or diagnostics. For more details on the selection criteria and invited companies, click here.

 

Registration Instructions

 

Presenter Toolkit

 

 Media Toolkit